A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF INTRAVENOUS MEMP1972A IN THE PREVENTION OF ALLERGEN-IN...
Mise à jour : Il y a 4 ans
Référence : EUCTR2010-021170-11